Mark Agulnik, MD
0 Patient Reviews

Mark Agulnik, MD

Other Healthcare Provider - General

Biography

Mark Agulnik, M.D., is a medical oncologist and section chief of sarcoma medical oncology the Department of Medical Oncology & Therapeutics Research at City of Hope.

Are you Mark Agulnik, MD?

Claim your 100% free Doctor.com profile to:

  • Respond to patient reviews
  • Customize your profile
  • Improve your visibility to our millions of monthly users
Claim your profile

Summary

Provider Training

UniversityDegreeFocusGraduated
McGill University Faculty of MedicineMedical DegreeNot Specified

InstitutionFocusYear
Residency - Mount Sinai Hospital Medical Center of Chicago Program Not Specified

Practice & Hospital Affiliations

  • Northwestern Memorial Hospital
       Chicago, Illinois - 60611

Photos

Provider Profile 0

Specialties

Languages Spoken
English
Medical Specialties
  • Other Healthcare Provider

Accepts New Patients: Yes

Payment Options

Payment Details

Reviews

Average Rating: None
Number of Reviews: 0
Most Recent Review: None
Write a Review

Office & Staff Evaluation Not rated

Ease of Getting an Appointment Not rated
Courtesy of Practice Staff Not rated
Office Appearance & Atmosphere Not rated
Handling of Billing Matters Not rated
Average Wait Time Not Rated

Locations

Affiliated Practices

Mark Agulnik, MD has not yet specified the practices where he works.
 

Procedures & Services

Procedures & Treatments Offered

  • Anemia
  • Bone Cancer
  • Chronic Pain
  • Colon Cancer
  • Extra Corporeal Shockwave Therapy
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Multiple Myeloma
  • Throat Cancer

Commonly Prescribed Medications

Mark Agulnik, MD has not yet listed the medications that he commonly prescribes.

Accepted Insurance

Accepted Insurance

Mark Agulnik, MD has not yet specified the insurance plans he accepts.
 

We use cookies and limited processing of your personal information for our website and services to function. By using our site, you agree to our use of cookies and our privacy policy.